By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Non-invasive diagnosis of eye, heart, and kidney diseases using AI reimbursed by insurance.
Currently we are working on Melanoma cancer, Cardiovascular Disease, and Chronic Kidney Disorders diagnosis - all from retina images and OCT. EyeCheckup is used by primary care for quick and affordable screening of eye, heart, and kidney disorders to replace comprehensive exams by the specialists. Autonomous diagnostic services are reimbursed by insurance in the USA and Czechia already.
Generative AI such as ChatGPT have become popular and very successful in diagnosing and treatment recommendations, however it works with text only and lacks contact with the patient. EyeCheckup becomes the eyes and hands of Generative AI and will replace human doctors in the near future.
We have completed six international clinical trials including the world renown Moorfields Eye Hospital and Kingston University. We have international publications in magazines like Nature Eye, IEEE Xplore, National Ophthalmology Congress, and more pending.
Co-invest alongside Ventures Thrive to accelerate the next generation of deeptech startups.
%20Turkey.webp)
Be a mentor, address key industry challenges, or co-invest alongside Ventures Thrive to accelerate the next generation of deeptech startups.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.
Ventures Thrive, project No 101073762 has received funding from the European Union’s Horizon Europe framework programme, under the European Innovation Council’s StartUpEU initiative.
